>
pdufa.bio

Onvansertib

Updated ยทnext FDA decision on the calendar

Onvansertib is a Cardiff Oncology, Inc. program. Its next catalyst is a Readout in Nov 2026. Every date links its source.

CRDF catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Cardiff Oncology, Inc. (CRDF). We track 3 catalyst events for this program: 2 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2026CRDFReadout · Nov 2026CRDFReadout · Dec 2026CRDF

Questions

When is Onvansertib's next FDA decision or readout?

The next tracked catalyst for Onvansertib is a Readout in Nov 2026.

What happened at Onvansertib's most recent FDA decision?

No FDA decision for Onvansertib is in our archive yet.

Who makes Onvansertib?

Cardiff Oncology, Inc. (CRDF).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.